<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30313034</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>22</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1536-5964</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>97</Volume>                    <Issue>41</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Medicine</Title>                <ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>            </Journal>            <ArticleTitle>The effectiveness of anticancer traditional Korean medicine treatment on the survival in patients with lung, breast, gastric, colorectal, hepatic, uterine, or ovarian cancer: A prospective cohort study protocol.</ArticleTitle>            <Pagination>                <MedlinePgn>e12444</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000012444</ELocationID>            <Abstract>                <AbstractText>Although anticancer traditional Korean medicine treatment (ACTKMT) is widely applied to patients with cancer together with, or in place of, conventional cancer treatment in Korea, the cohort evidence on its clinical effects is lacking. Therefore, this prospective cohort study is designed to evaluate the effect of ACTKMT on the survival and the clinical outcomes for patients being treated at an integrative oncology clinic.This is a single center, prospective cohort study of patients within 1 year after the diagnosis of primary lung, breast, gastric, colorectal, hepatic, uterine, or ovarian cancer. The event-free survival, disease-free survival/progression-free survival, the overall survival, the results of blood tests, and telomere-length information will be compared between patients receiving and patients not receiving a key ACTKMT (HangAmDan-B1, Geonchil-jung, and/or cultivated wild ginseng pharmacopuncture), and the correlation between the use of the key ACTKMT and the prognosis will be identified considering other risk factors.This study has received ethical approval from the Institutional Review Board, Dunsan Korean Medicine Hospital of Daejeon University (No. DJDSKH-16-BM-09). The results of this study will be published in a peer-reviewed journal.Clinical Research Information Service: KCT0002160.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Bae</LastName>                    <ForeName>Kyeore</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>East-West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Eunseok</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Acupuncture &amp; Moxibustion Medicine.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Choi</LastName>                    <ForeName>Jeong June</ForeName>                    <Initials>JJ</Initials>                    <AffiliationInfo>                        <Affiliation>Laboratory of Molecular Medicine, College of Korean Medicine, Daejeon University, Daejeon.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kim</LastName>                    <ForeName>Mi Kyung</ForeName>                    <Initials>MK</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Cancer Epidemiology and Management, National Cancer Center, Goyang, Republic of Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yoo</LastName>                    <ForeName>Hwa-Seung</ForeName>                    <Initials>HS</Initials>                    <AffiliationInfo>                        <Affiliation>East-West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D064888">Observational Study</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Medicine (Baltimore)</MedlineTA>            <NlmUniqueID>2985248R</NlmUniqueID>            <ISSNLinking>0025-7974</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>AIM</CitationSubset>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2012 Jun;23(6):1571-8</RefSource>                <PMID Version="1">22056972</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Chin Med. 2016;44(8):1719-1735</RefSource>                <PMID Version="1">27848251</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2017 Nov;37(11):5967-5974</RefSource>                <PMID Version="1">29061775</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Integr Cancer Ther. 2014 Jul;13(4):310-31</RefSource>                <PMID Version="1">24282099</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Evid Based Complement Alternat Med. 2016;2016:5738694</RefSource>                <PMID Version="1">27446225</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2017 Jan;67(1):7-30</RefSource>                <PMID Version="1">28055103</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Oncol. 2017 Aug;24(4):e269-e276</RefSource>                <PMID Version="1">28874897</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mediators Inflamm. 2014;2014:154561</RefSource>                <PMID Version="1">25024508</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2011 May;31(5):1801-6</RefSource>                <PMID Version="1">21617243</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 1993 Mar 3;85(5):365-76</RefSource>                <PMID Version="1">8433390</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Evid Based Complement Alternat Med. 2016;2016:1720239</RefSource>                <PMID Version="1">26977172</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pharmacopuncture. 2017 Dec;20(4):274-279</RefSource>                <PMID Version="1">30151297</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Evid Based Complement Alternat Med. 2014;2014:804746</RefSource>                <PMID Version="1">24899911</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2017 May 6;67(3):194-232</RefSource>                <PMID Version="1">28436999</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Acupunct Meridian Stud. 2011 Mar;4(1):61-8</RefSource>                <PMID Version="1">21440881</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biol Proced Online. 2011 Jan 31;13:3</RefSource>                <PMID Version="1">21369534</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pharm Pharmacol. 2013 Mar;65(3):457-64</RefSource>                <PMID Version="1">23356855</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2017 Aug 22;12(8):e0180918</RefSource>                <PMID Version="1">28829776</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Chin J Integr Med. 2017 Oct;23(10):733-739</RefSource>                <PMID Version="1">27796823</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Qual Life Res. 2004 May;13(4):863-8</RefSource>                <PMID Version="1">15129896</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2009 Jun 29;338:b2393</RefSource>                <PMID Version="1">19564179</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 1996 Jun;32A(7):1135-41</RefSource>                <PMID Version="1">8758243</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Integr Cancer Ther. 2012 Sep;11(3):187-203</RefSource>                <PMID Version="1">22019489</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Phytother Res. 2017 Apr;31(4):519-532</RefSource>                <PMID Version="1">28198055</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Integr Cancer Ther. 2008 Sep;7(3):182-8</RefSource>                <PMID Version="1">18815149</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Integr Cancer Ther. 2016 Dec;15(4):467-477</RefSource>                <PMID Version="1">27151594</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2013 Feb;24(2):489-94</RefSource>                <PMID Version="1">23110809</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2015 Nov 26;5:16776</RefSource>                <PMID Version="1">26608664</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biomed Biotechnol. 2012;2012:874276</RefSource>                <PMID Version="1">22174564</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2017 Sep 27;12(9):e0185254</RefSource>                <PMID Version="1">28953950</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D055670" MajorTopicYN="Y">Medicine, Korean Traditional</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D056910" MajorTopicYN="N">Republic of Korea</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30313034</ArticleId>            <ArticleId IdType="doi">10.1097/MD.0000000000012444</ArticleId>            <ArticleId IdType="pii">00005792-201810120-00016</ArticleId>            <ArticleId IdType="pmc">PMC6203506</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>